High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma

BACKGROUND: To report on the activity of high-dose prolonged-infusion ifosfamide (HDIFX) chemotherapy in a retrospective series of patients affected by myxoid liposarcoma treated at Fondazione IRCCS Istituto Nazionale dei Tumori in Milan, Italy. PATIENTS AND METHODS: Patients with an advanced myxoid...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sarcoma
Autors principals: Colia, Vittoria, Fumagalli, Elena, Provenzano, Salvatore, Bertulli, Rossella, Stacchiotti, Silvia, Morosi, Carlo, Collini, Paola, Gronchi, Alessandro, Casali, Paolo G., Sanfilippo, Roberta
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5602616/
https://ncbi.nlm.nih.gov/pubmed/28947876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/3739159
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars